BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 713415)

  • 1. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J; Liebau G; Steiner B; Hayduk K
    Klin Wochenschr; 1978 Sep; 56(17):859-64. PubMed ID: 713415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saralasin infusion in the recognition of renovascular hypertension.
    Wilson HM; Wilson JP; Slaton PE; Foster JH; Liddle GW; Hollifield JW
    Ann Intern Med; 1977 Jul; 87(1):36-42. PubMed ID: 879617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M; Bichara M; Grüfeld JP; Barbanel C; Meyer P; Funck-Brentano JL
    Nouv Presse Med; 1978 Feb; 7(7):539-43. PubMed ID: 643579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R; Lijnen P; Amery A; Reybrouck T
    Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)].
    Röckel A; Wernze H; Sabel B; Heidland A
    Klin Wochenschr; 1977 Jul; 55(13):651-6. PubMed ID: 895003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-negative saralasin responses in renovascular hypertension.
    Stokes GS; MacCarthy EP; Frost GW; Sheil AG
    Br J Urol; 1979 Apr; 51(2):92-9. PubMed ID: 465980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB; Atlas SA; Laragh JH
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET; Anderson GH; Goldman SH; Streeten DH
    Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The saralasin test in the diagnosis of hypertension (author's transl)].
    Bönner G; Helber A; Meurer KA; Hummerich W; Wambach G; Kaufmann W
    Dtsch Med Wochenschr; 1979 Mar; 104(12):432-7. PubMed ID: 436589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of saralasin to detect renovascular hypertension in childhood.
    Gillespie L; Ehrlich RM; Marks LS; Maxwell MH; Kaufman JJ
    Urology; 1980 Nov; 16(5):453-6. PubMed ID: 7003900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.